Zonova

Investor: THENA Capital

Zonova, an antimicrobial materials company focused on developing next-generation infection-resistant medical devices, has successfully secured £2.1 million in a Seed funding round led by THENA Capital.Summary of transaction details:Value: £2.1 millionSector: Healthcare & BiotechAdvisor: Not specifiedKey Entities: Zonova (Target), THENA Capital (Lead Investor)Location: London, UKNote: This Seed investment will enable Zonova to advance its pioneering work in antimicrobial materials, crucial for developing medical devices that combat infections and enhance patient safety within the healthcare sector.